Richard Eisenstadt
Director of Finance/CFO at ALTIMMUNE, INC.
Net worth: 324 086 $ as of 2024-04-29
Profile
Richard I.
Eisenstadt is currently the Chief Financial Officer & Director at Neostx, Inc. and the Chief Financial & Accounting Officer, Secretary at Altimmune, Inc. His former positions include Director-Strategic Planning & Development at Nimbus CD International, Inc., Finance Director at Cogent Neuroscience, Inc., Chief Financial Officer, Secretary & VP at OCERA Therapeutics LLC from 2003 to 2012, Chief Financial Officer & Secretary at Neos Therapeutics, Inc. from 2014 to 2021, Chief Financial Officer at ArborGen, Inc. from 2013 to 2014, Chief Financial Officer & Vice President-Finance at Tranzyme, Inc. from 2003 to 2012, Chief Financial Officer & Vice President-Finance at Tranzyme Pharma, Inc. (Canada) from 2003 to 2012, and Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. in 2021.
He holds an MBA from James Madison University and an undergraduate degree from The University of North Carolina at Charlotte.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALTIMMUNE, INC.
0.06% | 2024-01-30 | 45,012 ( 0.06% ) | 324 086 $ | 2024-04-29 |
Richard Eisenstadt active positions
| Companies | Position | Start |
|---|---|---|
| ALTIMMUNE, INC. | Director of Finance/CFO | 2021-12-30 |
Neostx, Inc.
 Neostx, Inc. Miscellaneous Commercial ServicesCommercial Services Neostx, Inc. develops, manufactures and commercialize branded products. The company was founded in 1994 and is headquartered in Grand Prairie, TX. | Director of Finance/CFO | - |
Former positions of Richard Eisenstadt
| Companies | Position | End |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director of Finance/CFO | 2021-12-29 |
| NEOS THERAPEUTICS, INC. | Director of Finance/CFO | 2021-03-18 |
ArborGen, Inc.
 ArborGen, Inc. Forest ProductsNon-Energy Minerals ArborGen, Inc. develops biotechnology tree seedling products. It also provides conventional and technology enhanced seedlings to the forestry industry. The firm's seedling products span the entire technology spectrum, from conventional seedlings to biotechnology seedlings. The company was founded on February 7, 2000 and is headquartered in Ridgeville, SC. | Director of Finance/CFO | 2014-04-30 |
| OCERA THERAPEUTICS INC | Director of Finance/CFO | 2012-11-30 |
| Tranzyme Pharma, Inc. (Canada) | Director of Finance/CFO | 2012-11-30 |
Training of Richard Eisenstadt
| James Madison University | Masters Business Admin |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
ArborGen, Inc.
ArborGen, Inc. Forest ProductsNon-Energy Minerals ArborGen, Inc. develops biotechnology tree seedling products. It also provides conventional and technology enhanced seedlings to the forestry industry. The firm's seedling products span the entire technology spectrum, from conventional seedlings to biotechnology seedlings. The company was founded on February 7, 2000 and is headquartered in Ridgeville, SC. | Non-Energy Minerals |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
| Cogent Neuroscience, Inc. | |
Nimbus CD International, Inc.
 Nimbus CD International, Inc. Movies/EntertainmentConsumer Services Nimbus CD International, Inc. manufactures compact discs and digital versatile discs which are used for the storage and playback of pre-recorded music as well as for the home video and other computer software. It supplies disks for United Kingdom and continental Europe regions. The company is headquartered in Ruckersville, VA. | Consumer Services |
Neostx, Inc.
Neostx, Inc. Miscellaneous Commercial ServicesCommercial Services Neostx, Inc. develops, manufactures and commercialize branded products. The company was founded in 1994 and is headquartered in Grand Prairie, TX. | Commercial Services |
| Tranzyme Pharma, Inc. (Canada) | |
| Tranzyme, Inc. /Old/ | Health Technology |
- Stock Market
- Insiders
- Richard Eisenstadt
